An 89-year-old male with a history of atrial fibrillation on Coumadin therapy is admitted for treatment of severe epistaxis secondary to the Coumadin therapy. ICD-10 Code ICD-10 Description R04.0 Epistaxis
Bleeding from the blood vessels in the nose.
Because the epistaxis is identified as an adverse effect of Coumadin codes 784.7, epistaxis, and E934.2, adverse effect of anticoagulant, are assigned as secondary diagnoses. Code 286.5 is not assigned in this instance because there is no hemorrhage disorder and Coumadin is not an intrinsic circulating anticoagulants.
Epistaxis 2016 2017 2018 2019 2020 2021 Billable/Specific Code R04.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM R04.0 became effective on October 1, 2020.
Hemorrhagic disorder due to extrinsic circulating anticoagulants. D68.32 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Hemorrhagic disorder due to extrinsic circulating anticoagulants. D68.32 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM D68.32 became effective on October 1, 2018.
ICD-10 code R04. 0 for Epistaxis is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
32: Hemorrhagic disorder due to extrinsic circulating anticoagulants.
Long term (current) use of anticoagulants Z79. 01 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79. 01 became effective on October 1, 2021.
R04. 0 - Epistaxis | ICD-10-CM.
Warfarin-induced coagulopathy Warfarin inhibits the hepatic synthesis of functional vitamin K–dependent clotting factors by blocking the recovery of the form of vitamin K that is active in the carboxylation for the calcium binding site of these proteins.
'Subtherapeutic INR levels' means that the patient is underwarfarinised, therefore as per ACS 0303 the correct code to assign is D68. 8 Other specified coagulation defects.
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
A: When physicians use a prothrombin time test (reported with CPT code 85610) to monitor patients on anticoagulant drugs, Medicare pays the entity that performed the test. Its payment for the test is based on the geographically specific laboratory test fee schedule.
Warfarin (brand name: Jantoven) is a prescription medication that interferes with normal blood clotting (coagulation). It is also called an anticoagulant. Warfarin is sold under the brand name Coumadin in some countries; however, this brand is no longer available in the United States or Canada.
784.7ICD-9 code 784.7 for Epistaxis is a medical classification as listed by WHO under the range -SYMPTOMS (780-789).
9: Fever, unspecified.
CPT 30901/30903 are used when you control epistaxis via means such as cautery but an endoscope is not used. CPT 31238 is reported when the epistaxis is treated while you're using an endoscope (ie, the scope and instrument to control epistaxis are parallel to each other in the nose).